Publications

Publications

China proposes new rules to address perceived anti-competitive practices in the pharmaceutical industry

On 14 August 2017, the National Development and Reform Commission ("NDRC") released a draft of the Guidelines on Pricing Conduct by Business Operators for Drugs in Shortage and Active...

Published Works

Healthcare mergers: Four key pieces of evidence used to predict the future

In this article, Leigh Oliver and Kim Rancour explain that merger litigation is most often an exercise in predicting the future competitive effects of a transaction. In order to do this,...

Published Works

It Is All About the Facts: Commentary on the Current State of Antitrust Enforcement in Health Care

This essay specifically addresses the conference presentations of professors Barak Richman and Tim Greaney, but also shares Leigh Oliver's views on the current state of antitrust...

Hogan Lovells Publications

Court upholds DOJ antitrust lawsuit challenging Carolinas HealthCare System's anti-steering provisions

Despite a recent decision by the Second Circuit suggesting that anti-steering contractual provisions in other industries may not be anticompetitive, DOJ's lawsuit (United States v....

Hogan Lovells Publications

Antitrust lawsuit against Carolinas Healthcare System shows DOJ support of steering, transparency initiatives

The antitrust agencies have made it clear that hospital mergers are a high enforcement priority. A new lawsuit, United States v. Carolinas Healthcare System, brought by the Department of...

Hogan Lovells Publications

Chinese Pharma Company Fined for Refusal to Supply Downstream Competitors

On 22 December 2015, the State Administration for Industry and Commerce (SAIC) published the decision of its local branch in Chongqing (Chongqing AIC) against pharma company Chongqing...

Published Works

Outlook for 2015: Antitrust Litigation in the Pharma Industry—More Than Just Actavis Progeny

In 2014 there were a number of significant antitrust developments related to litigation in the pharmaceutical industry. These involved not only pharmaceutical patent litigation settlements...

Published Works

Despite St. Luke's, The Efficiencies Defense Is Not Dead

For close to two years, antitrust lawyers as well as many observers in the health care community have been following closely the antitrust challenge brought by the Federal Trade Commission...

;
Loading data